Emtricitabine (FTC)
Emtricitabine (FTC) is a new nucleoside agent that has activity against both human immunodeficiency virus (HIV) and hepatitis B virus. It is a reverse transcriptase inhibitor. Intracellular half-life is 39 h.
| Trivial name | BW 1592 |
| Catalog Number | S1704 |
| Molecular Formula | C25H32N4O7S |
| CAS# | 143491-57-0 |
| Inchi | InChI=1S/C25H32N4O7S/c1-15-26-11-20(37-15)24(33)29-19(13-35-4)23(32)28-18(12-34-3)22(31)27-17(21(30)25(2)14-36-25)10-16-8-6-5-7-9-16/h5-9,11,17-19H,10,12-14H2,1-4H3,(H,27,31)(H,28,32)(H,29,33)/t17-,18 -,19-,25?/m0/s1 |
| Inchi Key | SWZXEVABPLUDIO-QNLBTCDKSA-N |
| SMILES | CC1=NC=C(S1)C(=O)NC(COC)C(=O)NC(COC)C(=O)NC(CC2=CC=CC=C2)C(=O)C3(CO3)C |
| Size | 10mM/1mL |
| Supplier Page | http://www.selleckchem.com/products/Emtricitabine.html |
| Additional Information | https://file.selleck.cn/downloads/struct/Emtricitabine-Emtriva-chemical-structure-S1704.gif |
